FDA Inspection
CA-BOTANA INTERNATIONALCA-BOTANA INTERNATIONAL – FDA Inspection, Apr 4, 2025
Record Details
This FDA Inspection record concerns CA-BOTANA INTERNATIONAL, with an inspection on April 4, 2025, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 4097df7d-d19a-456f-9e77-0d9663479097
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1265869
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.84(d)(1)Component identity verification
- 21 CFR 211.165(f)Failing drug products not rejected
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CA-BOTANA INTERNATIONAL
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 12, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 1, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for CA-BOTANA INTERNATIONAL
- FDA Inspection 1109655 - 2019-11-12
- FDA Inspection 963353 - 2016-01-12
- FDA Inspection 819672 - 2013-03-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.